Asset Details
Do you wish to reserve the book?
Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy
Do you wish to request the book?
Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy
2024
Overview
Due to the specific advantages of ultrasound (US) in therapeutic disease treatments, the unique therapeutic US technology has emerged. In addition to featuring a low‐invasive targeted cancer‐cell killing effect, the therapeutic US technology has been demonstrated to modulate the tumor immune landscape, amplify the therapeutic effect of other antitumor therapies, and induce immunosensitization of tumors to immunotherapy, shedding new light on the cancer treatment. Tremendous advances in nanotechnology are also expected to bring unprecedented benefits to enhancing the antitumor efficiency and immunological effects of therapeutic US, as well as therapeutic US‐derived bimodal and multimodal synergistic therapies. This comprehensive review summarizes the immunological effects induced by different therapeutic US technologies, including ultrasound‐mediated micro‐/nanobubble destruction (UTMD/UTND), sonodynamic therapy (SDT), and focused ultrasound (FUS), as well as the main underlying mechanisms involved. It is also discussed that the recent research progress of engineering intelligent nanoplatform in improving the antitumor efficiency of therapeutic US technologies. Finally, focusing on clinical translation, the key issues and challenges currently faced are summarized, and the prospects for promoting the clinical translation of these emerging nanomaterials and ultrasonic immunotherapy in the future are proposed.
This comprehensive review summarizes the immunological effects induced by different therapeutic ultrasound technologies, including ultrasound‐mediated microbubble destruction (UTMD), sonodynamic therapy (SDT), and focused ultrasound (FUS), as well as the main underlying mechanisms involved.
Publisher
John Wiley & Sons, Inc,Wiley
Subject
/ Tumors
We currently cannot retrieve any items related to this title. Kindly check back at a later time.